2:Linagliptin
Sponsors
Huashan Hospital, Fudan University
Conditions
Diabetic Kidney Diseasediabetic kidney disease
Phase 4
Exploratory study on the protective effect of Empagliflozin for diabetic kidney disease
Active, not recruitingChiCTR1900025788
Start: 2019-11-01Updated: 2019-09-09
Exploratory study on the protective effect of Empagliflozin on diabetic kidney disease: a randomized controlled trial.
Active, not recruitingChiCTR2000036701
Start: 2020-10-01Updated: 2020-09-21